Evaluating TERT promoter mutations and patient outcomes has demonstrated that the mutation can be an independent factor in predicting thyroid cancer shorter disease-free survival [114,118,119,120,121,122,123,124,125,126,127]. The gene discussed is TERT; the disease is thyroid gland carcinoma.